Amarillo, Texas — Amarillo, Texas

Amarillo, Texas is a clinical research site located in Amarillo, Texas, United States 79109.

Crixeo Health Trust Score: 61/100 (FAIR). This profile has not yet been claimed by the site owner.

Amarillo, Texas has participated in 3 clinical trials with 2 currently active.

Therapeutic areas: COVID-19, Diabetic Macular Edema (DME), Neovascular Age-related Macular Degeneration (NVAMD).

Sponsors: Quantum Biopharma, EyeBiotech Ltd..

Sponsor Feasibility Report

Trust Score: 61/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Amarillo, Texas?

Amarillo, Texas has a Crixeo Trust Score of 61/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Amarillo, Texas conducted?

Amarillo, Texas has 3 clinical trials on record, with 2 currently active. Their work covers COVID-19, Diabetic Macular Edema (DME), Neovascular Age-related Macular Degeneration (NVAMD).

Is Amarillo, Texas accredited by Crixeo Health?

Amarillo, Texas has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Amarillo, Texas?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.